Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn.
Davidson, D
Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. [electronic resource] - Pediatrics Aug 1999 - 231-6 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0031-4005
10.1542/peds.104.2.231 doi
Administration, Inhalation
Dose-Response Relationship, Drug
Double-Blind Method
Extracorporeal Membrane Oxygenation
Humans
Hypertension, Pulmonary--drug therapy
Nitric Oxide--administration & dosage
Treatment Failure
Treatment Outcome
Vasodilator Agents--administration & dosage
Safety of withdrawing inhaled nitric oxide therapy in persistent pulmonary hypertension of the newborn. [electronic resource] - Pediatrics Aug 1999 - 231-6 p. digital
Publication Type: Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
0031-4005
10.1542/peds.104.2.231 doi
Administration, Inhalation
Dose-Response Relationship, Drug
Double-Blind Method
Extracorporeal Membrane Oxygenation
Humans
Hypertension, Pulmonary--drug therapy
Nitric Oxide--administration & dosage
Treatment Failure
Treatment Outcome
Vasodilator Agents--administration & dosage